Peter and Dan continue their conversation about the recent Abundance Platinum Longevity trip, where Peter and a select group of entrepreneurs, executives and investors spent five days learning from the top longevity and immunology experts in two of California’s top biotech hubs.

In this episode:

Peter and Dan discuss the explosion of sensors and preventive medicine breakthroughs now emerging at the helm of today’s healthcare market. As smartphone apps and AI more seamlessly enable personalized medicine, consumers will soon be able to monitor and act upon their own health data in real-time.

Peter explores his biggest takeaways in the field of CRISPR and genetic engineering. Most notably, Peter showcases Mammoth Biosciences, a pioneering startup on a mission to democratize access to next-generation CRISPR tools for diagnostics and therapeutics. 

Peter highlights the importance of cutting out sugar from your diet, a shift critically conducive to improving longevity outcomes. He similarly emphasizes his belief that the biggest contributor to living past 80 is to not die from something stupid.